# A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer

> **NCT07110363** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Biotroy Therapeutics** · enrollment: 58 (estimated)

## Conditions studied

- Advanced Malignant Solid Tumor
- Advanced Lung Cancer
- Non-Small Cell Lung Cancer
- Small Cell Lung Cancer

## Interventions

- **DRUG:** BT02

## Key facts

- **NCT ID:** NCT07110363
- **Lead sponsor:** Biotroy Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08
- **Primary completion:** 2027-03
- **Final completion:** 2027-05
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2025-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07110363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07110363, "A Clinical Study of BT02 in Treating Patients With Advanced Lung Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07110363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*